Bacterial vaginosis secondary prevention

Jump to: navigation, search

Sexually transmitted diseases Main Page

Vaginitis Main Page

Bacterial vaginosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bacterial vaginosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Amsel Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bacterial vaginosis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bacterial vaginosis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bacterial vaginosis secondary prevention

CDC on Bacterial vaginosis secondary prevention

Bacterial vaginosis secondary prevention in the news

Blogs on Bacterial vaginosis secondary prevention

Directions to Hospitals Treating Bacterial vaginosis

Risk calculators and risk factors for Bacterial vaginosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Effective measure for the secondary prevention of infective conjunctivitis include maintaining vaginal pH at 4.5, bacteriotherapy, avoid douching and change in the method of contraception.[1][2][3][4]

Secondary prevention

Effective measure for the secondary prevention of infective conjunctivitis include:[1][2][3][4]

  • Maintaining vaginal pH at 4.5
    • Use intravaginal lactate gel
    • Bacteriotherapy
  • Stop douching
  • Changing the method of contraception

References

  1. 1.0 1.1 Wilson J (2004). "Managing recurrent bacterial vaginosis.". Sex Transm Infect. 80 (1): 8–11. PMC 1758381Freely accessible. PMID 14755028. 
  2. 2.0 2.1 Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM; et al. (2013). "Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.". Clin Infect Dis. 56 (6): 777–86. PMID 23243173. doi:10.1093/cid/cis1030. 
  3. 3.0 3.1 Reid G, Beuerman D, Heinemann C, Bruce AW (2001). "Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.". FEMS Immunol Med Microbiol. 32 (1): 37–41. PMID 11750220. 
  4. 4.0 4.1 Andersch B, Lindell D, Dahlén I, Brandberg A (1990). "Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel.". Gynecol Obstet Invest. 30 (2): 114–9. PMID 2245947. 

Linked-in.jpg